AEPWM
DFTX

Atlantic Edge Private Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65K Hold
193
– – ﹤0.01% 489
2025
Q4 		$2.58K Hold
193
– – ﹤0.01% 508
2025
Q3 		$2.28K Hold
193
– – ﹤0.01% 492
2025
Q2 		$1.25K Hold
193
– – ﹤0.01% 485
2025
Q1 		$1.13K Buy
+193
New +$1.38K ﹤0.01% 474

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlantic Edge Private Wealth Management's DFTX Position: Q1 2026 in Review

Atlantic Edge Private Wealth Management held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 193 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Atlantic Edge Private Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Atlantic Edge Private Wealth Management held 193 shares of Definium Therapeutics worth $3.65K as of Q1 2026.
  • Atlantic Edge Private Wealth Management left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q1 2026, its #489 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.